Predicting Outcome in Head and Neck Cancer: miRNAs with Potentially Big Effects.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30413524.
- Also identified by DOI 10.1158/1078-0432.CCR-18-3078 and PMC identifier 6415532.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A five-miRNA signature for human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) identifies patients at risk for inferior outcomes. Combining established clinical variables with this novel miRNA signature affords an opportunity to personalize and intensify treatment strategies in this high-risk patient population.<i>See related article by Hess et al., p. 1505</i>.
Medical subject headings
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
- MicroRNAs
- Papillomavirus Infections
- Squamous Cell Carcinoma of Head and Neck